TIMP-1 and responsiveness to gemcitabine in advanced breast cancer: results from a randomized phase III trial from the Danish breast cancer cooperative group
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Dokumenter
- TIMP-1 and responsiveness to gemcitabine in advanced breast cancer; results from a randomized phase III trial from the Danish breast cancer cooperative group
Forlagets udgivne version, 618 KB, PDF-dokument
Originalsprog | Engelsk |
---|---|
Artikelnummer | 360 |
Tidsskrift | B M C Cancer |
Vol/bind | 14 |
Antal sider | 14 |
ISSN | 1471-2407 |
DOI | |
Status | Udgivet - 2014 |
Antal downloads er baseret på statistik fra Google Scholar og www.ku.dk
Ingen data tilgængelig
ID: 125791294